Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot study.
Zhao P, An ZY, Fu HX, Liu HX, Feng CJ, Huang QS, Wu J, Wu YJ, Yang LP, Qu QY, Chen YX, Li ML, Wang CC, Chen Q, Zhu XL, He Y, Zhang YY, Jiang Q, Jiang H, Lu J, Chang YJ, Zhao XS, Zhao XY, Huang XJ, Zhang XH.
Zhao P, et al. Among authors: zhao xs.
Am J Hematol. 2024 Oct;99(10):1951-1958. doi: 10.1002/ajh.27433. Epub 2024 Jul 9.
Am J Hematol. 2024.
PMID: 38980207
Clinical Trial.